Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Schlesinger

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
International Journal of Molecular Sciences|March 29, 2023
Exostosin 1 Knockdown Induces Chemoresistance in MV3 Melanoma Cells by Upregulating JNK and MEK/ERK SignalingVladlena Pfeifer, Heiko Weber, Yuanyuan Wang, et al.
Physical Review. E|January 21, 2023
Finite-time Lyapunov fluctuations and the upper bound of classical and quantum out-of-time-ordered expansion rate exponentsMiguel A Prado Reynoso, Guilherme J Delben, Martin Schlesinger, et al.
Archiv Der Pharmazie|June 26, 2021
Another structural correction for 1-oxo-1H-phenalene-2,3-dicarbonitriles: Synthesis of a potent BCL-2 inhibiting 7-phenoxy derivativeIzidor Sosič, Martina Gobec, Christian Steinebach, et al.
Biochemical Pharmacology|August 5, 2015
Low molecular weight heparin tinzaparin antagonizes cisplatin resistance of ovarian cancer cellsDaniel Bastian Pfankuchen, Daniel Philipp Stölting, Martin Schlesinger, et al.
International Journal of Clinical Pharmacology and Therapeutics|August 27, 2015
Lysophosphatidylcholine attenuates melanoma cell adhesion and migration dependent on the degree of fatty acid saturationThomas Ross, Sebastian Heuter, Martin Schlesinger, et al.
FEBS Open Bio|March 4, 2017
The molecular mechanism by which saturated lysophosphatidylcholine attenuates the metastatic capacity of melanoma cellsThomas Ross, Bastian Jakubzig, Manuel Grundmann, et al.
Thrombosis Research|November 22, 2011
The inhibition of the integrin VLA-4 in MV3 melanoma cell binding by non-anticoagulant heparin derivativesMartin Schlesinger, Patrick Schmitz, Reiner Zeisig, et al.
Oncotarget|October 6, 2017
Heparin antagonizes cisplatin resistance of A2780 ovarian cancer cells by affecting the Wnt signaling pathwayDaniel Bastian Pfankuchen, Fabian Baltes, Tahira Batool, et al.
Molecules (Basel, Switzerland)|March 1, 2020
Glycosaminoglycans as Tools to Decipher the Platelet Tumor Cell Interaction: A Focus on P-SelectinSvenja Schwarz, Lukas Maria Gockel, Annamaria Naggi, et al.
Molecules (Basel, Switzerland)|May 4, 2017
The Impact of the Low Molecular Weight Heparin Tinzaparin on the Sensitization of Cisplatin-Resistant Ovarian Cancers-Preclinical In Vivo Evaluation in Xenograft Tumor ModelsThomas Mueller, Daniel Bastian Pfankuchen, Kathleen Wantoch von Rekowski, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
International Journal of Molecular Sciences|March 29, 2023
Exostosin 1 Knockdown Induces Chemoresistance in MV3 Melanoma Cells by Upregulating JNK and MEK/ERK SignalingVladlena Pfeifer, Heiko Weber, Yuanyuan Wang, et al.
Physical Review. E|January 21, 2023
Finite-time Lyapunov fluctuations and the upper bound of classical and quantum out-of-time-ordered expansion rate exponentsMiguel A Prado Reynoso, Guilherme J Delben, Martin Schlesinger, et al.
Archiv Der Pharmazie|June 26, 2021
Another structural correction for 1-oxo-1H-phenalene-2,3-dicarbonitriles: Synthesis of a potent BCL-2 inhibiting 7-phenoxy derivativeIzidor Sosič, Martina Gobec, Christian Steinebach, et al.
Biochemical Pharmacology|August 5, 2015
Low molecular weight heparin tinzaparin antagonizes cisplatin resistance of ovarian cancer cellsDaniel Bastian Pfankuchen, Daniel Philipp Stölting, Martin Schlesinger, et al.
International Journal of Clinical Pharmacology and Therapeutics|August 27, 2015
Lysophosphatidylcholine attenuates melanoma cell adhesion and migration dependent on the degree of fatty acid saturationThomas Ross, Sebastian Heuter, Martin Schlesinger, et al.
FEBS Open Bio|March 4, 2017
The molecular mechanism by which saturated lysophosphatidylcholine attenuates the metastatic capacity of melanoma cellsThomas Ross, Bastian Jakubzig, Manuel Grundmann, et al.
Thrombosis Research|November 22, 2011
The inhibition of the integrin VLA-4 in MV3 melanoma cell binding by non-anticoagulant heparin derivativesMartin Schlesinger, Patrick Schmitz, Reiner Zeisig, et al.
Oncotarget|October 6, 2017
Heparin antagonizes cisplatin resistance of A2780 ovarian cancer cells by affecting the Wnt signaling pathwayDaniel Bastian Pfankuchen, Fabian Baltes, Tahira Batool, et al.
Molecules (Basel, Switzerland)|March 1, 2020
Glycosaminoglycans as Tools to Decipher the Platelet Tumor Cell Interaction: A Focus on P-SelectinSvenja Schwarz, Lukas Maria Gockel, Annamaria Naggi, et al.
Molecules (Basel, Switzerland)|May 4, 2017
The Impact of the Low Molecular Weight Heparin Tinzaparin on the Sensitization of Cisplatin-Resistant Ovarian Cancers-Preclinical In Vivo Evaluation in Xenograft Tumor ModelsThomas Mueller, Daniel Bastian Pfankuchen, Kathleen Wantoch von Rekowski, et al.
Pageof 5